National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting, 29872 [2016-11257]
Download as PDF
<![CDATA[
29872
Federal Register / Vol. 81, No. 93 / Friday, May 13, 2016 / Notices
Electronic responses are
preferred and should be addressed or
submitted to either: (1) The online
platform, Cancer Research Ideas, at
https://cancerresearchideas.cancer.gov;
or (2) email to cancerresearch@nih.gov.
Non-electronic responses will also be
accepted by calling the NCI Cancer
Information Service at 1–800–422–6237
or by mail to Blue Ribbon Panel,
National Cancer Moonshot Initiative,
National Cancer Institute, 9609 Medical
Center Drive, Bethesda, MD 20892–
9760.
FOR FURTHER INFORMATION: Questions
about this request for information
should be directed to Kelli Marciel,
National Cancer Institute, 9609 Medical
Center Drive, Bethesda, MD 20892–
9760, Kelli.Marciel@nih.gov, 301–594–
3330.
SUPPLEMENTARY INFORMATION: During his
State of the Union address on January
12, 2016, President Barack Obama
announced the establishment of a new
National Cancer Moonshot Initiative to
accelerate cancer research. The
initiative, led by Vice President Joe
Biden, aims to make more therapies
available to more patients, while also
improving our ability to prevent cancer
and detect it at an early stage.
Additional details of the National
Cancer Moonshot Initiative are available
at https://www.cancer.gov/research/keyinitiatives/moonshot-cancer-initiative.
The White House and Vice President
Biden have named a Task Force of 13
heads of federal agencies and offices
who will advise the administration on
research priorities. To ensure that the
National Cancer Moonshot Initiative’s
goals and approaches are grounded in
the best science, President Obama
directed the Moonshot Task Force to
consult with external experts, including
the presidentially appointed National
Cancer Advisory Board (NCAB). A Blue
Ribbon Panel of experts has been
established as a working group of the
NCAB that will assist the board in
providing this advice.
The Blue Ribbon Panel is composed
of leading experts from a broad range of
scientific areas, including biology,
immunology, genomics, diagnostics,
bioinformatics, and cancer prevention
and treatment. Members also include
investigators with expertise in clinical
trials and cancer health disparities. In
addition to researchers, the panel
membership also includes clinicians
and nurses, and representatives of
cancer advocacy organizations and the
pharmaceutical and biotechnology
industries.
The Blue Ribbon Panel will focus on
identifying scientific opportunities in
mstockstill on DSK3G9T082PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
18:05 May 12, 2016
Jkt 238001
cancer research that could produce
major advances with additional
emphasis and funding, and propose
ways to overcome barriers to pursuing
these opportunities.
Community input is critical to the
success of the National Cancer
Moonshot Initiative. Indeed, the success
of the initiative will depend on breaking
down silos and encouraging everyone
with an interest in fighting cancer to
work together, share information, and
collaborate on solutions. To enable the
Blue Ribbon Panel to consider a wide
range of input from researchers,
scientists, physicians, advocates,
students, data scientists, and members
of the public, anyone with a scientific
idea or suggestion for addressing cancer
research challenges can contribute by
visiting https://
cancerresearchideas.cancer.gov.
Input is sought in the following areas:
• Expanding clinical trials
• Enhanced data sharing
• Cancer immunology and prevention
• Implementation sciences
• Pediatric cancer
• Precision, prevention and early
detection
• Tumor evolution and progression
This RFI is for planning purposes
only and should not be construed as a
solicitation for applications or
proposals, or as an obligation in any
way on the part of the United States
Federal government. The Federal
government will not pay for the
preparation of any information
submitted or for the government’s use.
Additionally, the government cannot
guarantee the confidentiality of the
information provided.
Dated: May 5, 2016.
Dinah Singer,
Acting Deputy Director, National Cancer
Institute.
[FR Doc. 2016–11283 Filed 5–12–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; RFA Review and Reverse
Site Visit of INIA NEUROIMMUNE
Consortium.
Date: June 24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott New Orleans, 614 Canal
Street, New Orleans, LA 70130.
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm.
2081, Rockville, MD 20852, 301–443–0800,
bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: May 9, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11257 Filed 5–12–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\13MYN1.SGM
13MYN1
]]>Agencies
[Federal Register Volume 81, Number 93 (Friday, May 13, 2016)]
[Notices]
[Page 29872]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11257]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; RFA Review and Reverse Site Visit
of INIA NEUROIMMUNE Consortium.
Date: June 24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott New Orleans, 614 Canal Street, New Orleans, LA
70130.
Contact Person: Beata Buzas, Ph.D., Scientific Review Officer,
National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm. 2081, Rockville, MD
20852, 301-443-0800, bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards., National Institutes of
Health, HHS)
Dated: May 9, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-11257 Filed 5-12-16; 8:45 am]
BILLING CODE 4140-01-P
